HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
Not recruitingISRCTN44737909

Effects of agomelatine on sleep electroencephalogram parameters compared to selective serotonin reuptake inhibitors in patients with major depressive disorder: a six-week randomised, double-blind parallel group study versus comparator, followed by a double-blind optional treatment extension period up to six months

Research studyAges 18+Multiple countriesDepression
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations
United Kingdom · Australia and 7 more locations
Compensation
Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Institut de Recherches Internationales Servier (France)
Sponsor type
Research institute
Study type
Other
Intervention type
Other / unclear
Study phase
Not clearly listed
Locations
Australia, France, United Kingdom, ...
Age range
Over 18 Years
Official registry ID
ISRCTN44737909
Official title
Show the full official title

Effects of agomelatine on sleep electroencephalogram parameters compared to selective serotonin reuptake inhibitors in patients with major depressive disorder: a six-week randomised, double-blind parallel group study versus comparator, followed by a double-blind optional treatment extension period up to six months

Questions about this study?

The HopeStage team will email you.

Loading the security check...

Recruitment & locations

Not recruiting

United Kingdom · Australia · Austria

6 more locations
  • Brazil
  • Finland
  • France
  • Germany
  • Spain
  • Taiwan
Checked Official study record (opens in a new tab)

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Institut de Recherches Internationales Servier (France), a research institute.

Who can participate?

This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as not recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me